Myocardial InfarctionCR MI FCNCT07867197
Effectiveness of Digital Cardiac Rehabilitation on Functional Capacity in Patients With Myocardial Infarction
A study testing Conventional Treatment group and Digital and Conventional treatment in people with Myocardial Infarction and Tele-rehabilitation, run by Cairo University at 1 site in Egypt.
Trial summary
The goal of this clinical trial is to learn if a digital health-supported cardiac rehabilitation program works to improve functional capacity, adherence, quality of life, and psychological status in cardiac patients. Read more about this study
- Who is it for?
- Ages 55 to 65 years
- Conditions the study is for
- Myocardial Infarction, Tele-rehabilitation, FUCTIONAL MOBILITY
- What is being tested?
- Conventional Treatment group and Digital and Conventional treatment
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 6 Jun 2026to Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Men and women aged 55-65 years.
- Medically stable patients with a documented history of myocardial infarction who have been referred for Phase II outpatient cardiac rehabilitation.
- Body mass index (BMI) between 30.0 and 39.9 kg/m² (Obesity Classes I and II).
- Clearance from a cardiologist to participate in the prescribed exercise program.
- Ability to walk independently, with or without an assistive device.
- Ownership of a smartphone with stable internet access, or availability of a caregiver who can assist with smartphone use.
- Willingness to follow the study procedures and provide written informed consent.
Who cannot join
- Unstable angina or decompensated heart failure.
- Uncontrolled arrhythmias, uncontrolled hypertension, or any other contraindication to exercise training.
- A recent major cardiac event or intervention that has not yet been medically stabilized.
- Severe orthopedic, neurological, or pulmonary conditions that limit exercise testing or training.
- Severe cognitive impairment or communication difficulties that prevent adequate cooperation.
- Severe visual or hearing impairment that prevents safe use of the required digital technologies.
- Inability or unwillingness to use the digital rehabilitation platform, even with caregiver assistance.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Mohamed S Farghaly, B.Sc. in Physical Therapy contact
Egypt1 site, 1 recruiting
- Recruiting
Faculty of Physical Therapy, Deraya University
Minya, Minya Province
Mohamed S Farghaly, BSc in Physical Therapy, 01006833073, mohamedshahin938@gmail.com
About this study
Official title: EFFECTIVENESS OF A DIGITAL HEALTH-GUIDED CARDIAC REHABILITATION PROGRAM ON FUNCTIONAL CAPACITY, AND QUALITY OF LIFE IN PATIENTS WITH MYOCARDIAL INFARCTION
The goal of this clinical trial is to learn if a digital health-supported cardiac rehabilitation program works to improve functional capacity, adherence, quality of life, and psychological status in cardiac patients. It will also learn about the effect of digital health support when added to conventional outpatient cardiac rehabilitation.
The main questions it aims to answer are:
Read more
Does a digital health-supported cardiac rehabilitation program improve functional capacity?
How does digital health support affect patients' adherence to cardiac rehabilitation?
How does the program affect patients' quality of life and psychological status?
Researchers will compare digital health-supported cardiac rehabilitation combined with conventional outpatient cardiac rehabilitation to conventional outpatient cardiac rehabilitation alone to determine whether digital support improves functional, behavioral, and psychological outcomes in phase II cardiac patients.
Participants will:
Be randomly assigned to receive either digital health-supported hybrid cardiac rehabilitation in addition to conventional outpatient cardiac rehabilitation or conventional outpatient cardiac rehabilitation alone.
Have their functional exercise capacity assessed using the Six-Minute Walk Test (6MWT) as the primary outcome measure.
Complete assessments to evaluate cardiac rehabilitation adherence and engagement, health-related quality of life, and psychological status.
Have resting heart rate and blood pressure monitored as part of the clinical assessment.
Participants in the digital health-supported group will also use digital health tools for activity monitoring, exercise adherence, reminders, education, communication, and weekly telecoaching.
Read the detailed description
The Challenge:
Limited Participation in Cardiac Rehabilitation Cardiac rehabilitation is an important part of recovery and secondary prevention for patients with cardiovascular disease. However, participation in conventional center-based cardiac rehabilitation remains limited because of several barriers, including transportation difficulties, cost, work and family commitments, limited referral, and limited availability of rehabilitation programs. These barriers can be particularly challenging for patients living in underserved or low-resource settings, where participation and completion of rehabilitation programs may be poor.
The Goal of the Study :
This study aims to discover if a digital health-supported cardiac rehabilitation program can help improve functional capacity, adherence, quality of life, and psychological status in cardiac patients. Specifically, the research will evaluate the effect of adding digital health support to conventional outpatient cardiac rehabilitation compared with conventional cardiac rehabilitation alone.
How the Study Works? The study will involve 60 medically stable cardiac patients, both men and women, aged 55-65 years, who are eligible for Phase II outpatient cardiac rehabilitation following myocardial infarction and primary percutaneous coronary intervention.
These participants will be randomly divided into two equal groups:
The Digital Health-Supported Group: Participants will receive digital health-supported hybrid cardiac rehabilitation in addition to conventional outpatient cardiac rehabilitation for 12 weeks, with three sessions per week. They will use digital tools to support exercise adherence, activity monitoring, education, reminders, communication, and weekly telecoaching.
The Control Group: Participants will receive conventional outpatient cardiac rehabilitation alone for 12 weeks, with three sessions per week. They will also receive brief weekly phone contact without digital coaching.
Both groups will continue their prescribed medications and usual medical follow-up.
What is Being Measured?
To accurately determine whether the digital health-supported program is effective, the study will evaluate several key areas:
Functional Capacity: The Six-Minute Walk Test (6MWT) will be used as the primary outcome measure to assess functional exercise capacity by measuring the distance participants can walk in six minutes under standardized conditions.
Adherence and Engagement:
The study will assess adherence to the prescribed cardiac rehabilitation sessions. For participants receiving digital support, additional indicators such as platform use, completion of educational modules, and logged home-based activity will also be monitored.
Quality of Life:
Health-related quality of life will be evaluated using the MacNew Heart Disease Health-Related Quality of Life Questionnaire, which assesses physical, emotional, and social functioning.
Psychological Status:
Psychological status will be assessed using the Hospital Anxiety and Depression Scale (HADS) to evaluate symptoms of anxiety and depression.
Physiological Measures:
Resting heart rate and blood pressure will also be assessed as part of the clinical evaluation.
Why This Matters Because participation in conventional cardiac rehabilitation can be affected by geographical, financial, and logistical barriers, finding accessible ways to support patients beyond the rehabilitation center is important. Digital health technologies such as smartphone applications, wearable monitoring, remote communication, and telecoaching may help patients remain engaged with their rehabilitation program.
By comparing digital health-supported cardiac rehabilitation with conventional outpatient cardiac rehabilitation alone, this study hopes to determine whether digital support can provide additional benefits in functional capacity, adherence, quality of life, and psychological status among Phase II cardiac patients.
- Being tested
- Conventional Treatment group, Digital and Conventional treatment
- Medical subject headings
- Myocardial Infarction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Conventional Treatment groupProcedure or surgery
Duration \& Frequency: A 12-week supervised program with 3 sessions per week for both groups.
Session Structure: Warm-up (5-10 min): Low-intensity stretching and rhythmic movements.
Aerobic Training (20-40 min): Treadmill exercise prescribed at 40%-60% Heart Rate Reserve (HRR) using the Karvonen formula.
Precision Intensity Target:
HR{max} is derived from a symptom-limited exercise stress test (rather than age-predicted formulas) to keep intensity safely below the patient's ischemic or symptomatic threshold.
Resistance \& Cool-down: Major muscle group resistance training (1-2 sets of 10-15 reps), cool-down exercises, and breathing techniques.
Patient Education: Covers risk-factor modification, medication adherence (e.g., beta-blockers), nutrition, and smoking cessation for secondary prevention.
Digital and Conventional treatmentProcedure or surgery
Treatment Procedure for the Digital Component:·
In addition to the conventional outpatient program, participants in the experimental group will receive a digital support package comprising:
An initial orientation session on application use, symptom reporting, exercise safety, and home monitoring.
A smartphone application and/or secure messaging platform for education, reminders, and communication.· A smart phone for step counting and activity monitoring.· Home-based walking or prescribed physical activity on non-clinic days, logged through the digital platform.· Weekly tele coaching or teleconsultation to review progress, symptoms, barriers, and goals.· Automated reminders and motivational messages to support adherence.· Clinician-reviewed adjustment of home activity targets based on symptoms, safety criteria, and monitored activity data.
| Study group | Role | What they receive |
|---|---|---|
| Group A (Study Group): Participants received a 12-week digital health-supported hybrid cardiac rehab | Experimental | Group A (Study Group): Participants received a 12-week digital health-supported hybrid cardiac rehabilitation program in addition to conventional outpatient cardiac rehabilitation, with three rehabilitation sessions per week. Receives: Procedure: Digital and Conventional treatment |
| Group B (Control Group): Participants received conventional center-based outpatient cardiac rehabili | Other | Group B (Control Group): Participants received conventional center-based outpatient cardiac rehabilitation for 12 weeks, with three sessions per week. The control group received brief weekly telephone contact without digital coaching Receives: Procedure: Conventional Treatment group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Six-Minute Walk Test (6MWT):
Functional exercise capacity was evaluated using the 6MWT to determine the total Six-Minute Walk Distance (6MWD) in meters. The assessment adhered to standardized American Thoracic Society (ATS) guidelines, utilizing a 30-meter flat, unobstructed indoor corridor. Standardized encouragement phrases were provided at 1-minute intervals.
To eliminate the learning effect, a practice walk was conducted prior to baseline data collection. Continuous heart rate dynamics during the walk were monitored using a synchronized smartwatch (Huawei Watch Fit 3, Huawei Technologies Co., Ltd.). The 6MWD was evaluated at baseline and following the 12-week intervention period
Measured: 12 weeks
Secondary outcomes (5)
Cardiac Rehabilitation Adherence & Engagement Scale
Adherence will be assessed based on the proportion of prescribed supervised cardiac rehabilitation sessions successfully completed during the 12-week program. For the digital health-supported group, digital engagement will also be assessed through platform utilization, completion of educational modules, and logged home-based activity sessions.
Measured: throughout the 12-week intervention period.
Health-Related Quality of Life (HRQoL)
Health-related quality of life will be assessed using the MacNew Heart Disease Health-Related Quality of Life Questionnaire (MacNew), a 27-item cardiac-specific questionnaire evaluating physical, emotional, and social functioning.
Measured: Baseline (pre-intervention) and at week 12 (post-intervention).
Psychological Status
Anxiety and depression symptoms will be assessed using the Hospital Anxiety and Depression Scale (HADS), a 14-item self-report questionnaire designed to evaluate psychological distress.
Measured: Baseline (pre-intervention) and at week 12 (post-intervention).
Resting Heart Rate (RHR)
Resting heart rate will be assessed as a physiological measure to evaluate cardiovascular response and autonomic balance.
Measured: Baseline (pre-intervention) and at week 12 (post-intervention).
Blood Pressure (BP)
Systolic and diastolic blood pressure will be monitored as physiological measures during the cardiac rehabilitation program.
Measured: (pre-intervention) and at week 12 (post-intervention).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Oct 2026
- Study start6 Jun 2026
- Primary completionOct 2026 (estimated)
- Study completionNov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Myocardial InfarctionStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Shahin Farghaly Ali, Cairo University
- Investigators
- MARWA M ELSAYED, Assistant Professor, Study chair, Cairo UniversitySANDRA A GUIRGUIS, Lecturer, Study director, Cairo UniversityMIOHAMED G ABDEL NABY FARAG, Lecturer, Study director, Minia University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07867197
- Sponsor's protocol ID
- P.T.REC/012/006640
- Acronym
- CR MI FC
- Status last verified
- Oct 2026
- First submitted
- 5 Oct 2026
- Last updated
- 9 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared to maintain participant privacy and strictly adhere to confidentiality agreements.
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- EFFECTIVENESS OF A DIGITAL HEALTH-GUIDED CARDIAC REHABILITATION PROGRAM ON FUNCTIONAL CAPACITY, AND QUALITY OF LIFE IN PATIENTS WITH MYOCARDIAL INFARCTION
- ClinicalTrials.gov ID
- NCT07867197
- Acronym / sponsor ID
- CR MI FC / P.T.REC/012/006640
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 6 Jun 2026 (actual)
- Primary completion
- Oct 2026 (estimated)
- Study completion
- Nov 2026 (estimated)
- First posted
- 9 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if a digital health-supported cardiac rehabilitation program works to improve functional capacity, adherence, quality of life, and psychological status in cardiac patients. It will also learn about the effect of digital health support when added to conventional outpatient cardiac rehabilitation.
The main questions it aims to answer are:
Does a digital health-supported cardiac rehabilitation program improve functional capacity?
How does digital health support affect patients' adherence to cardiac rehabilitation?
How does the program affect patients' quality of life and psychological status?
Researchers will compare digital health-supported cardiac rehabilitation combined with conventional outpatient cardiac rehabilitation to conventional outpatient cardiac rehabilitation alone to determine whether digital support improves functional, behavioral, and psychological outcomes in phase II cardiac patients.
Participants will:
Be randomly assigned to receive either digital health-supported hybrid cardiac rehabilitation in addition to conventional outpatient cardiac rehabilitation or conventional outpatient cardiac rehabilitation alone.
Have their functional exercise capacity assessed using the Six-Minute Walk Test (6MWT) as the primary outcome measure.
Complete assessments to evaluate cardiac rehabilitation adherence and engagement, health-related quality of life, and psychological status.
Have resting heart rate and blood pressure monitored as part of the clinical assessment.
Participants in the digital health-supported group will also use digital health tools for activity monitoring, exercise adherence, reminders, education, communication, and weekly telecoaching.
Detailed description
The Challenge:
Limited Participation in Cardiac Rehabilitation Cardiac rehabilitation is an important part of recovery and secondary prevention for patients with cardiovascular disease. However, participation in conventional center-based cardiac rehabilitation remains limited because of several barriers, including transportation difficulties, cost, work and family commitments, limited referral, and limited availability of rehabilitation programs. These barriers can be particularly challenging for patients living in underserved or low-resource settings, where participation and completion of rehabilitation programs may be poor.
The Goal of the Study :
This study aims to discover if a digital health-supported cardiac rehabilitation program can help improve functional capacity, adherence, quality of life, and psychological status in cardiac patients. Specifically, the research will evaluate the effect of adding digital health support to conventional outpatient cardiac rehabilitation compared with conventional cardiac rehabilitation alone.
How the Study Works? The study will involve 60 medically stable cardiac patients, both men and women, aged 55-65 years, who are eligible for Phase II outpatient cardiac rehabilitation following myocardial infarction and primary percutaneous coronary intervention.
These participants will be randomly divided into two equal groups:
The Digital Health-Supported Group: Participants will receive digital health-supported hybrid cardiac rehabilitation in addition to conventional outpatient cardiac rehabilitation for 12 weeks, with three sessions per week. They will use digital tools to support exercise adherence, activity monitoring, education, reminders, communication, and weekly telecoaching.
The Control Group: Participants will receive conventional outpatient cardiac rehabilitation alone for 12 weeks, with three sessions per week. They will also receive brief weekly phone contact without digital coaching.
Both groups will continue their prescribed medications and usual medical follow-up.
What is Being Measured?
To accurately determine whether the digital health-supported program is effective, the study will evaluate several key areas:
Functional Capacity: The Six-Minute Walk Test (6MWT) will be used as the primary outcome measure to assess functional exercise capacity by measuring the distance participants can walk in six minutes under standardized conditions.
Adherence and Engagement:
The study will assess adherence to the prescribed cardiac rehabilitation sessions. For participants receiving digital support, additional indicators such as platform use, completion of educational modules, and logged home-based activity will also be monitored.
Quality of Life:
Health-related quality of life will be evaluated using the MacNew Heart Disease Health-Related Quality of Life Questionnaire, which assesses physical, emotional, and social functioning.
Psychological Status:
Psychological status will be assessed using the Hospital Anxiety and Depression Scale (HADS) to evaluate symptoms of anxiety and depression.
Physiological Measures:
Resting heart rate and blood pressure will also be assessed as part of the clinical evaluation.
Why This Matters Because participation in conventional cardiac rehabilitation can be affected by geographical, financial, and logistical barriers, finding accessible ways to support patients beyond the rehabilitation center is important. Digital health technologies such as smartphone applications, wearable monitoring, remote communication, and telecoaching may help patients remain engaged with their rehabilitation program.
By comparing digital health-supported cardiac rehabilitation with conventional outpatient cardiac rehabilitation alone, this study hopes to determine whether digital support can provide additional benefits in functional capacity, adherence, quality of life, and psychological status among Phase II cardiac patients.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group A (Study Group): Participants received a 12-week digital health-supported hybrid cardiac rehab | Experimental | Procedure: Digital and Conventional treatmentGroup A (Study Group): Participants received a 12-week digital health-supported hybrid cardiac rehabilitation program in addition to conventional outpatient cardiac rehabilitation, with three rehabilitation sessions per week. |
| Group B (Control Group): Participants received conventional center-based outpatient cardiac rehabili | Other | Procedure: Conventional Treatment groupGroup B (Control Group): Participants received conventional center-based outpatient cardiac rehabilitation for 12 weeks, with three sessions per week. The control group received brief weekly telephone contact without digital coaching |
Who may qualify
- Ages
- 55 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Men and women aged 55-65 years.
- Medically stable patients with a documented history of myocardial infarction who have been referred for Phase II outpatient cardiac rehabilitation.
- Body mass index (BMI) between 30.0 and 39.9 kg/m² (Obesity Classes I and II).
- Clearance from a cardiologist to participate in the prescribed exercise program.
- Ability to walk independently, with or without an assistive device.
Key exclusion criteria (7 listed)
- Unstable angina or decompensated heart failure.
- Uncontrolled arrhythmias, uncontrolled hypertension, or any other contraindication to exercise training.
- A recent major cardiac event or intervention that has not yet been medically stabilized.
- Severe orthopedic, neurological, or pulmonary conditions that limit exercise testing or training.
- Severe cognitive impairment or communication difficulties that prevent adequate cooperation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Conventional Treatment groupDuration \& Frequency: A 12-week supervised program with 3 sessions per week for both groups. Session Structure: Warm-up (5-10 min): Low-intensity stretching and rhythmic movements. Aerobic Training (20-40 min): Treadmill exercise prescribed at 40%-60% Heart Rate Reserve (HRR) using the Karvonen formula. Precision Intensity Target: HR{max} is derived from a symptom-limited exercise stress test (rather than age-predicted formulas) to keep intensity safely below the patient's ischemic or symptomatic threshold. Resistance \& Cool-down: Major muscle group resistance training (1-2 sets of 10-15 reps), cool-down exercises, and breathing techniques. Patient Education: Covers risk-factor modification, medication adherence (e.g., beta-blockers), nutrition, and smoking cessation for secondary prevention. | Procedure or surgery | Group B (Control Group): Participants received conventional center-based outpatient cardiac rehabili |
| Digital and Conventional treatmentTreatment Procedure for the Digital Component:· In addition to the conventional outpatient program, participants in the experimental group will receive a digital support package comprising: An initial orientation session on application use, symptom reporting, exercise safety, and home monitoring. A smartphone application and/or secure messaging platform for education, reminders, and communication.· A smart phone for step counting and activity monitoring.· Home-based walking or prescribed physical activity on non-clinic days, logged through the digital platform.· Weekly tele coaching or teleconsultation to review progress, symptoms, barriers, and goals.· Automated reminders and motivational messages to support adherence.· Clinician-reviewed adjustment of home activity targets based on symptoms, safety criteria, and monitored activity data. | Procedure or surgery | Group A (Study Group): Participants received a 12-week digital health-supported hybrid cardiac rehab |
Primary outcome
Six-Minute Walk Test (6MWT):
Time frame: 12 weeks
Functional exercise capacity was evaluated using the 6MWT to determine the total Six-Minute Walk Distance (6MWD) in meters. The assessment adhered to standardized American Thoracic Society (ATS) guidelines, utilizing a 30-meter flat, unobstructed indoor corridor. Standardized encouragement phrases were provided at 1-minute intervals. To eliminate the learning effect, a practice walk was conducted prior to baseline data collection. Continuous heart rate dynamics during the walk were monitored using a synchronized smartwatch (Huawei Watch Fit 3, Huawei Technologies Co., Ltd.). The 6MWD was evaluated at baseline and following the 12-week intervention period
5 secondary outcomes
Cardiac Rehabilitation Adherence & Engagement Scale
Time frame: throughout the 12-week intervention period.
Health-Related Quality of Life (HRQoL)
Time frame: Baseline (pre-intervention) and at week 12 (post-intervention).
Psychological Status
Time frame: Baseline (pre-intervention) and at week 12 (post-intervention).
Resting Heart Rate (RHR)
Time frame: Baseline (pre-intervention) and at week 12 (post-intervention).
Blood Pressure (BP)
Time frame: (pre-intervention) and at week 12 (post-intervention).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared to maintain participant privacy and strictly adhere to confidentiality agreements.
Related trials for Myocardial Infarction
Not yet recruitingPhase 4
Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
Coronary Artery Disease, Coronary Artery Bypass Grafting
Active, not recruitingObservational study
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Hypertension, Diabetes
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
Enrolling by invitation
The DANE-HEART Trial - Computed Tomography Coronary Angiography for Primary Prevention
Coronary Atherosclerosis and Other Heart Disease, Cardiovascular Diseases
Not yet recruitingObservational study
Elicit Drugs in Myocardial Infarction
Young Patients With Acute Myocardial Infarction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mohamed S Farghaly, B.Sc. in Physical Therapy contact
MARWA M ELSAYED, Assistant Professor study chair
Cairo University
SANDRA A GUIRGUIS, Lecturer study director
Cairo University
MIOHAMED G ABDEL NABY FARAG, Lecturer study director
Minia University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Conventional Treatment group and Digital and Conventional treatment in people with Myocardial Infarction and Tele-rehabilitation, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mohamed S Farghaly, B.Sc. in Physical Therapy (+20 01006833073 ext. +2001016602066, mohamedshahin938@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Six-Minute Walk Test (6MWT): (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.